Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    PTN Net Margin

    As of 2025-05-22, the Net Margin of Palatin Technologies Inc (PTN) is -662.3%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    PTN Net Margin - Historical Value
    DateValue
    2024-06-30 -662.3%
    2023-06-30 -567.8%
    2022-06-30 -2462.6%
    2021-06-30 17684.2%
    2020-06-30 -18691.7%
    2019-06-30 59.3%
    2018-06-30 36.8%
    2017-06-30 -29.8%
    2016-06-30 -
    2015-06-30 -136.5%
    PTN Net Margin - Peers Comparison
    TickerNameValue
    AEZS.TOAeterna Zentaris Inc-368%
    ALRNAileron Therapeutics Inc14.7%
    ARAVAravive Inc-835%
    ATNF180 Life Sciences Corp-
    ATOSAtossa Therapeutics Inc-36650%
    AXLAAxcella Health Inc-
    AYLAOld Ayala Inc-1148.1%
    BCLIBrainstorm Cell Therapeutics Inc-
    CELCCelcuity Inc-
    DYAIDyadic International Inc-166.2%
    ENLVEnlivex Therapeutics Ltd-
    ENOBEnochian Biosciences Inc-4350%
    EVAXEvaxion Biotech A/S-316%
    FENCFennec Pharmaceuticals Inc-0.9%
    GLTOGalecto Inc-
    INMBINmune Bio Inc-300585.7%
    LGVNLongeveron Inc-667.8%
    LPTXLeap Therapeutics Inc-2705.8%
    NYMXNymox Pharmaceutical Corp-117400%
    ONC.TOOncolytics Biotech Inc-1164.5%
    PHGEBiomx Inc-
    PSTIPluristem Therapeutics Inc-145750%
    SCPSScopus Biopharma Inc-
    SYBXSynlogic Inc-291987.5%
    TARAProtara Therapeutics Inc-113.2%
    TCONTRACON Pharmaceuticals Inc-29.8%
    WLLW.TOWillow Biosciences Inc-132.8%
    XFORX4 Pharmaceuticals Inc-1464.6%
    Tickers added to watchlist